Bericht
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
Like other rights, patent rights are not absolute. There are situations in which their exercise can be limited to protect public interests. Such situations may arise, for instance, when access to needed pharmaceutical products must be ensured. Compulsory licenses and government use for non-commercial purposes are tools, provided for under most laws worldwide, that can specifically be used to address public health needs. This document is intended to provide legal guidance for the effective use of such tools, consistently with the international law.
- Sprache
-
Englisch
- Erschienen in
-
Series: Research Paper ; No. 107
- Klassifikation
-
Sozialwissenschaften, Soziologie, Anthropologie
- Thema
-
Access to Medicines
Affordable Medicines
Compulsory Licenses
COVID-19
Data Exclusivity
Diagnostics
Doha Declaration on the TRIPS Agreement and Public Health
Evergreening
Flexibilities
Global Health
Government Use
Health
Innovation
Intellectual Property
Least Developed Countries (LDCs)
Patent
Pharmaceuticals
Public Health
Research and Development (R&D)
TRIPS
Vaccines
Voluntary License
WHO
WHO Global Strategy (GSPOA)
World Health Organization (WHO)
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Correa, Carlos María
- Ereignis
-
Veröffentlichung
- (wer)
-
South Centre
- (wo)
-
Geneva
- (wann)
-
2020
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Bericht
Beteiligte
- Correa, Carlos María
- South Centre
Entstanden
- 2020
Ähnliche Objekte (12)
Pharmaceutical innovation, incremental patenting and compulsory licensing
Promoting Jordan's use of compulsory licensing during the pandemic
Compulsory licensing jurisprudence in South Africa: Do we have our priorities right?
The right to health in pharmaceutical patent disputes
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Implementing pro-competitive criteria for the examination of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
Rethinking Global Health: A Binding Convention for R&D for Pharmaceutical Products
Pharmaceutical innovation, incremental patenting and compulsory licensing
Promoting Jordan's use of compulsory licensing during the pandemic
Compulsory licensing jurisprudence in South Africa: Do we have our priorities right?
The right to health in pharmaceutical patent disputes
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Implementing pro-competitive criteria for the examination of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
Rethinking Global Health: A Binding Convention for R&D for Pharmaceutical Products
Pharmaceutical innovation, incremental patenting and compulsory licensing
Promoting Jordan's use of compulsory licensing during the pandemic
Compulsory licensing jurisprudence in South Africa: Do we have our priorities right?
The right to health in pharmaceutical patent disputes
Access to medicines: Experiences with compulsory licenses and government use - The case of Hepatitis C
Implementing pro-competitive criteria for the examination of pharmaceutical patents
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance